Project Grant R21AG089279
Award Date 9/1/25
Completion Date 8/31/27
Dollars Obligated $405K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Iowa, USA
Similar Awards
- The National Institute on Aging (NIA) awarded a $1,558,726 Project Grant under the Aging Research program (CFDA 93.866) to the University of Pittsburgh. The grant, titled "MENOBRAIN: A Longitudinal Investigation of Menopause and Brain Health," will conduct a 5-year study to elucidate the brain and cognitive changes that occur during the perimenopause phase of the menopause transition, and the factors contributing to these changes. The study will recruit 224 women in the late...
- This $4,765,698 federal Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) will fund a research study by the University of California, Santa Barbara to investigate the effects of endocrine aging on spatial navigation ability and its neuronal systems. The project will enroll 240 cognitively normal midlife adults, with a balanced distribution of pre-, peri-, and post-menopausal women, and use immersive virtual environments and brain imaging to elucidate how...
- This $880,000 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund a study to examine the effects of daily stress, sleep, and sex hormones on accelerated vascular aging in premenopausal midlife women. The 2-year study, starting November 2024, will investigate how emotional reactivity to daily stressors and sleep variability contribute to vascular dysfunction prior to menopause, and how these factors interact with changes in estradiol levels. The...
- The National Institute on Aging (NIA), part of the U.S. Department of Health and Human Services, awarded a $4,055,366 Project Grant under the Aging Research federal grant program (CFDA 93.866) to the University of Southern California (USC). The grant, awarded on September 15, 2025, aims to investigate the impact of exposure to endocrine-disrupting persistent organic pollutants during the menopausal transition on cognition, brain activity, and Alzheimer's disease (AD) biomarkers. The project...
- This $3,377,863 Project Grant was awarded on September 15, 2025 by the National Institute on Aging (CFDA 93.866 Aging Research) to the Mayo Clinic in Minnesota. The objective is to analyze women-specific health patterns from electronic health records to address diagnostic disparities in the progression of cognitive impairment and dementia. The project aims to leverage precision medicine approaches to better understand how factors unique to women, such as menopause and pregnancy, may impact...
- This $625,898 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to develop spatially-informed, cell-specific metabolic models of the ovary to identify novel biomarkers associated with the onset and duration of the menopause transition. The key products and services to be delivered include: Generation of spatially-informed, cell-specific, multicellular genome-scale metabolic models (GMMs) of the ovary using single-cell and spatial transcriptomics data...
- The National Institute on Aging, under the Aging Research Federal Grant Program (CFDA 93.866), awarded a $3,754,882 project grant to Mayo Clinic to investigate the effects of premenopausal bilateral oophorectomy (PBO) on imaging biomarkers of Alzheimer's disease and cerebrovascular disease in women. The project aims to enroll 400 women, including an African American cohort from Mayo Clinic Florida, to study how the abrupt disruption of ovarian hormones before natural menopause impacts the...
- The U.S. National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), awarded a $2,329,970 Project Grant to the University of Florida to conduct research on "Evaluation of the Neuroimmune Mechanisms Influencing Therapeutic Targeting Potential of the LH/CG Receptor in the Menopausal and AD Brain". This 4-year project, running from September 1, 2025 to August 31, 2029, seeks to investigate the potential immune-regulating role of the LH/CG receptor...
- This Project Grant award, valued at $2,129,396.00, was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The award aims to develop and validate engineered adeno-associated viruses (AAVs) that can selectively knock down the follicle-stimulating hormone receptor (FSHR) in neurons within brain regions vulnerable to Alzheimer's disease. This research seeks to understand the role of FSH signaling in cognitive decline and Alzheimer's...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $3,531,593.00 to Vanderbilt University Medical Center to conduct research on the role of sex-specific genetic factors in the development and progression of cerebrovascular disease (CVD) within the Alzheimer's disease (AD)-affected brain. The research aims to: 1) identify sex-specific genetic markers of autopsy measures of brain vessel disease, 2) identify sex-specific genetic markers of...